tiprankstipranks
Trending News
More News >

David Arkowitz Insider Profile

11 Followers
David Arkowitz, CFO at Flexion Therapeutics, holds 0.00 shares in Kineta (Ticker: KANT), holds 18.38K shares in Ibio (Ticker: IBIO), holds 182.44K shares in Seres Therapeutics (Ticker: MCRB).
tipranks
David Arkowitz

David Arkowitz
Flexion Therapeutics (~FLXN)
CFO

Ranked #88,037 out of 102,674 Corporate Insiders

Profitable Transactions

20%
1 out of 5 Profitable Transactions

Average Return

-29.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
99.52%
0.48%
A breakdown of David Arkowitz's holdings

Insider Roles

Seres Therapeutics
(MCRB)
CFO
Ibio
(IBIO)
Director
Roles that David Arkowitz holds in companies

Most Profitable Insider Trade

Stock:
Flexion Therapeutics
(~FLXN)
Rating:Informative Buy
Date:Jun 03, 2019 - Jun 03, 2020
Return:+9.30%
The most profitable trade made by David Arkowitz

David Arkowitz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
~FLXN
Flexion Therapeutics
May 12, 2021
Informative Sell
16.12K
$2.01M
FSTX
F-star Therapeutics
Mar 09, 2023
Uninformative Sell
59.71K
$0.00
KANT
Kineta
Jul 02, 2025
Uninformative Sell
$0.00
Seres Therapeutics
Feb 16, 2024
CFO
Uninformative Buy
7.49K
$2.60M
Ibio
Jan 13, 2025
Director
Informative Buy
50.00K
$12.50K
AMAG
Amag Pharmaceuticals
Jun 01, 2011
Uninformative Buy
19.84K
$24.83K
IDIX
Idenix Pharma
List of latest transactions for each holding click on a transaction to see David Arkowitz's performance on stock

David Arkowitz insider profile FAQ

What is the percentage of profitable transactions made by David Arkowitz?
The percentage of profitable transactions made by David Arkowitz is 20%.
    What is the average return per transaction made by David Arkowitz?
    The average return per transaction made by David Arkowitz is -29.30%.
      What stocks does David Arkowitz hold?
      David Arkowitz holds: ~FLXN, FSTX, KANT, MCRB, IBIO, AMAG, IDIX stocks.
        What was David Arkowitz’s latest transaction?
        David Arkowitz latest transaction was an Uninformative Sell of ―.
          What was David Arkowitz's most profitable transaction?
          David Arkowitz’s most profitable transaction was an Informative Buy of ~FLXN stock on June 3, 2019. The return on the trade was 9.30%.
            What is David Arkowitz's role in Flexion Therapeutics?
            David Arkowitz's role in Flexion Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.